{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:40:58Z","timestamp":1791236458061,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T00:00:00Z","timestamp":1281484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s11095-010-0235-2","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T12:41:39Z","timestamp":1281444099000},"page":"2296-2306","source":"Crossref","is-referenced-by-count":46,"title":["Multifunctional Tumor-Targeted Polymer-Peptide-Drug Delivery System for Treatment of Primary and Metastatic Cancers"],"prefix":"10.1007","volume":"27","author":[{"given":"Pooja","family":"Chandna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant J.","family":"Khandare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Rodriguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Minko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,11]]},"reference":[{"issue":"1","key":"235_CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2004.12.044","volume":"97","author":"MS Piver","year":"2005","unstructured":"Piver MS. 16, 090: the 2004 estimated U.S. mortality from ovarian cancer. Gynecol Oncol. 2005;97(1):301\u20132.","journal-title":"Gynecol Oncol."},{"issue":"Suppl 4","key":"235_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/annonc\/4.suppl_4.S57","volume":"4","author":"EG Vries de","year":"1993","unstructured":"de Vries EG, Hamilton TC, Lind M, Dauplat J, Neijt JP, Ozols RF. Advanced ovarian cancer. Drug resistance, supportive care and dose intensity. Ann Oncol. 1993;4 Suppl 4:57\u201362.","journal-title":"Ann Oncol."},{"issue":"7","key":"235_CR3","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1200\/JCO.1999.17.7.2061","volume":"17","author":"M Baekelandt","year":"1999","unstructured":"Baekelandt M, Kristensen GB, Nesland JM, Trope CG, Holm R. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer. J Clin Oncol. 1999;17(7):2061\u20138.","journal-title":"J Clin Oncol."},{"issue":"9","key":"235_CR4","first-page":"2178","volume":"56","author":"JJ Herod","year":"1996","unstructured":"Herod JJ, Eliopoulos AG, Warwick J, Niedobitek G, Young LS, Kerr DJ. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res. 1996;56(9):2178\u201384.","journal-title":"Cancer Res."},{"issue":"8","key":"235_CR5","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0959-8049(99)00124-0","volume":"35","author":"Y Mano","year":"1999","unstructured":"Mano Y, Kikuchi Y, Yamamoto K, Kita T, Hirata J, Tode T, et al. Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. Eur J Cancer. 1999;35(8):1214\u20139.","journal-title":"Eur J Cancer."},{"issue":"9","key":"235_CR6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1054\/bjoc.2001.2101","volume":"85","author":"M Schuyer","year":"2001","unstructured":"Schuyer M, van der Burg ME, Henzen-Logmans SC, Fieret JH, Klijn JG, Look MP, et al. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2. Br J Cancer. 2001;85(9):1359\u201367.","journal-title":"Br J Cancer."},{"issue":"6","key":"235_CR7","first-page":"426","volume":"50","author":"A Berkenblit","year":"2005","unstructured":"Berkenblit A, Cannistra SA. Advances in the management of epithelial ovarian cancer. J Reprod Med. 2005;50(6):426\u201338.","journal-title":"J Reprod Med."},{"issue":"1","key":"235_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1568006053005038","volume":"5","author":"T Kawaguchi","year":"2005","unstructured":"Kawaguchi T. Cancer metastasis: characterization and identification of the behavior of metastatic tumor cells and the cell adhesion molecules, including carbohydrates. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5(1):39\u201364.","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord."},{"issue":"4","key":"235_CR9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/1389450043345443","volume":"5","author":"T Minko","year":"2004","unstructured":"Minko T, Dharap SS, Pakunlu RI, Wang Y. Molecular targeting of drug delivery systems to cancer. Curr Drug Targets. 2004;5(4):389\u2013406.","journal-title":"Curr Drug Targets."},{"issue":"5","key":"235_CR10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/mp070053o","volume":"4","author":"P Chandna","year":"2007","unstructured":"Chandna P, Saad M, Wang Y, Ber E, Khandare J, Vetcher AA, et al. Targeted proapoptotic anticancer drug delivery system. Mol Pharm. 2007;4(5):668\u201378.","journal-title":"Mol Pharm."},{"issue":"3","key":"235_CR11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1124\/jpet.105.094243","volume":"316","author":"SS Dharap","year":"2006","unstructured":"Dharap SS, Chandna P, Wang Y, Khandare JJ, Qiu B, Stein S, et al. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy. J Pharmacol Exp Ther. 2006;316(3):992\u20138.","journal-title":"J Pharmacol Exp Ther."},{"issue":"1\u20132","key":"235_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-3659(03)00209-8","volume":"91","author":"SS Dharap","year":"2003","unstructured":"Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release. 2003;91(1\u20132):61\u201373.","journal-title":"J Control Release."},{"issue":"36","key":"235_CR13","doi-asserted-by":"crossref","first-page":"12962","DOI":"10.1073\/pnas.0504274102","volume":"102","author":"SS Dharap","year":"2005","unstructured":"Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, et al. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci USA. 2005;102(36):12962\u20137.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"235_CR14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/jpet.105.098855","volume":"317","author":"JJ Khandare","year":"2006","unstructured":"Khandare JJ, Chandna P, Wang Y, Pozharov VP, Minko T. Novel polymeric prodrug with multivalent components for cancer therapy. J Pharmacol Exp Ther. 2006;317(3):929\u201337.","journal-title":"J Pharmacol Exp Ther."},{"issue":"2","key":"235_CR15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2008.05.024","volume":"130","author":"M Saad","year":"2008","unstructured":"Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, et al. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? J Control Release. 2008;130(2):107\u201314.","journal-title":"J Control Release."},{"issue":"6","key":"235_CR16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/17435889.3.6.761","volume":"3","author":"M Saad","year":"2008","unstructured":"Saad M, Garbuzenko OB, Minko T. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomed. 2008;3(6):761\u201376.","journal-title":"Nanomed."},{"issue":"5","key":"235_CR17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","volume":"18","author":"AA Ayantunde","year":"2007","unstructured":"Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18(5):945\u20139.","journal-title":"Ann Oncol."},{"issue":"6","key":"235_CR18","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/endo-109-6-2040","volume":"109","author":"PM Conn","year":"1981","unstructured":"Conn PM, Hazum E. Luteinizing hormone release and gonadotropin-releasing hormone (GnRH) receptor internalization: independent actions of GnRH. Endocrinology. 1981;109(6):2040\u20135.","journal-title":"Endocrinology."},{"key":"235_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1385\/1-59259-406-9:133","volume-title":"Cancer cell culture: methods and protocols, Vol. 88","author":"SP Langdon","year":"2003","unstructured":"Langdon SP. Isolation and Culture of Ovarian Cancer Cell Lines. In: Langdon SP, editor. Cancer cell culture: methods and protocols, Vol. 88. Totowa: Humana Press; 2003. p. 133\u20139."},{"issue":"1","key":"235_CR20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<108::AID-IJC17>3.0.CO;2-8","volume":"86","author":"T Minko","year":"2000","unstructured":"Minko T, Kopeckova P, Kopecek J. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer. 2000;86(1):108\u201317.","journal-title":"Int J Cancer."},{"issue":"5","key":"235_CR21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1007500412442","volume":"17","author":"T Minko","year":"2000","unstructured":"Minko T, Kopeckova P, Pozharov V, Jensen KD, Kopecek J. The influence of cytotoxicity of macromolecules and of VEGF gene modulated vascular permeability on the enhanced permeability and retention effect in resistant solid tumors. Pharm Res. 2000;17(5):505\u201314.","journal-title":"Pharm Res."},{"issue":"11","key":"235_CR22","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1158\/1078-0432.CCR-07-2020","volume":"14","author":"Y Wang","year":"2008","unstructured":"Wang Y, Saad M, Pakunlu RI, Khandare JJ, Garbuzenko OB, Vetcher AA, et al. Nonviral Nanoscale-Based Delivery of Antisense Oligonucleotides Targeted to Hypoxia-Inducible Factor 1{alpha} Enhances the Efficacy of Chemotherapy in Drug-Resistant Tumor. Clin Cancer Res. 2008;14(11):3607\u201316.","journal-title":"Clin Cancer Res."},{"issue":"6","key":"235_CR23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1023\/A:1023839319950","volume":"20","author":"SS Dharap","year":"2003","unstructured":"Dharap SS, Minko T. Targeted proapoptotic LHRH-BH3 peptide. Pharm Res. 2003;20(6):889\u201396.","journal-title":"Pharm Res."},{"issue":"11","key":"235_CR24","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s11095-007-9406-1","volume":"24","author":"S Jayant","year":"2007","unstructured":"Jayant S, Khandare JJ, Wang Y, Singh AP, Vorsa N, Minko T. Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment. Pharm Res. 2007;24(11):2120\u201330.","journal-title":"Pharm Res."},{"issue":"3","key":"235_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1022687617318","volume":"20","author":"RI Pakunlu","year":"2003","unstructured":"Pakunlu RI, Cook TJ, Minko T. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin. Pharm Res. 2003;20(3):351\u20139.","journal-title":"Pharm Res."},{"key":"235_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2006.06.010","volume":"114","author":"RI Pakunlu","year":"2006","unstructured":"Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. J Control Release. 2006;114:153\u201362.","journal-title":"J Control Release."},{"issue":"3","key":"235_CR27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2009.06.019","volume":"140","author":"O Taratula","year":"2009","unstructured":"Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, Pozharov VP, et al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J Control Release. 2009;140(3):284\u201393.","journal-title":"J Control Release."},{"issue":"6","key":"235_CR28","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1021\/bc060240p","volume":"17","author":"JJ Khandare","year":"2006","unstructured":"Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, Vorsa N, et al. Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of Paclitaxel. Bioconjug Chem. 2006;17(6):1464\u201372.","journal-title":"Bioconjug Chem."},{"issue":"1","key":"235_CR29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00001622-199901000-00014","volume":"11","author":"JC Reed","year":"1999","unstructured":"Reed JC. Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol. 1999;11(1):68\u201375.","journal-title":"Curr Opin Oncol."},{"issue":"6","key":"235_CR30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.cdd.4400386","volume":"5","author":"B Zhivotovsky","year":"1998","unstructured":"Zhivotovsky B, Hanson KP, Orrenius S. Back to the future: the role of cytochrome c in cell death. Cell Death Differ. 1998;5(6):459\u201360.","journal-title":"Cell Death Differ."},{"issue":"5381","key":"235_CR31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","volume":"281","author":"NA Thornberry","year":"1998","unstructured":"Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281(5381):1312\u20136.","journal-title":"Science."},{"issue":"4","key":"235_CR32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02905214","volume":"4","author":"G Szakacs","year":"1998","unstructured":"Szakacs G, Jakab K, Antal F, Sarkadi B. Diagnostics of multidrug resistance in cancer. Pathol Oncol Res. 1998;4(4):251\u20137.","journal-title":"Pathol Oncol Res."},{"issue":"1\u20132","key":"235_CR33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0005-2728(98)00039-5","volume":"1365","author":"HW Veen van","year":"1998","unstructured":"van Veen HW, Konings WN. The ABC family of multidrug transporters in microorganisms. Biochim Biophys Acta. 1998;1365(1\u20132):31\u20136.","journal-title":"Biochim Biophys Acta."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0235-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-010-0235-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0235-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:54:01Z","timestamp":1559354041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-010-0235-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1007\/s11095-010-0235-2","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,11]]}}}